The Safety and Effectiveness of Ganciclovir in the Prevention of Cytomegalovirus (CMV) of the Eyes and Disease of the Stomach and Intestines in Patients With HIV

NCT00001034 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

850

Enrollment

NIH

Sponsor class

Conditions

Cytomegalovirus Retinitis
HIV Infections
Gastrointestinal Diseases

Interventions

DRUG: Ganciclovir

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]